Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improving survival in molecularly selected glioblastoma.

Literature DB >> 30782332

Improving survival in molecularly selected glioblastoma.

Roger Stupp¹, Rimas V Lukas², Monika E Hegi³.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2019 PMID： 30782332 DOI： 10.1016/S0140-6736(18)33211-2

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors: Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal: Neuro Oncol Date: 2020-08-17 Impact factor: 12.300

Review 2. Clinical neuro-oncology for the neurologist.

Authors: Rimas V Lukas; Jennie W Taylor; Sylvia C Kurz; Nimish A Mohile
Journal: Neurol Clin Pract Date: 2020-10

3. Knockdown of T Cell Immunoglobulin and Mucin 1 (Tim-1) Suppresses Glioma Progression Through Inhibition of the Cytokine-PI3K/AKT Pathway.

Authors: Peng Zhou; Maoxing Fei; Yanling Han; Mengliang Zhou; Handong Wang
Journal: Onco Targets Ther Date: 2020-08-04 Impact factor: 4.147

Review 4. Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.

Authors: Yunping Chen; Yan Jin; Nan Wu
Journal: Cells Date: 2021-02-28 Impact factor: 6.600

5. Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response.

Authors: Marco Pizzocri; Francesca Re; Elisabetta Stanzani; Beatrice Formicola; Matteo Tamborini; Eliana Lauranzano; Federica Ungaro; Simona Rodighiero; Maura Francolini; Maria Gregori; Alessandro Perin; Francesco DiMeco; Massimo Masserini; Michela Matteoli; Lorena Passoni
Journal: Neurooncol Adv Date: 2021-06-18

Improving survival in molecularly selected glioblastoma.

Review 1. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Review 2. Clinical neuro-oncology for the neurologist.

3. Knockdown of T Cell Immunoglobulin and Mucin 1 (Tim-1) Suppresses Glioma Progression Through Inhibition of the Cytokine-PI3K/AKT Pathway.

Review 4. Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.

5. Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response.

6. SLC39A7 promotes malignant behaviors in glioma via the TNF-α-mediated NF-κB signaling pathway.

Review 7. Metabolic Drivers of Invasion in Glioblastoma.

8. Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.

Review 9. DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.

10. The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma.